Development of an enzyme-linked immunosorbent assay for the measurement of plasma growth hormone (GH) levels in channel catfish (Ictalurus punctatus): assessment of environmental salinity and GH secretogogues on plasma GH levels.
Drennon. Katherine K; Moriyama. Shunsuke S; Kawauchi. Hiroshi H; Small. Brian B; Silverstein. Jeffrey J; Parhar. Ishwar I; Shepherd. Brian B
Key Findings
- A sensitive ELISA was developed to accurately measure catfish growth hormone in plasma.
- Injecting the synthetic peptide GHRP‑2 (KP‑102) significantly increased plasma GH levels in catfish.
- Switching catfish from fresh water to brackish water also caused a strong rise in GH, showing a salinity‑related GH response.
Practical Outcomes
- The study confirms that GHRP‑2 can act as a GH‑secretagogue in a non‑mammalian species, supporting the idea that the peptide can stimulate GH release. However, because the work was done in catfish, the findings are not directly transferable to human dosing or protocols. Biohackers should view this as mechanistic evidence rather than actionable guidance for human use.
Summary
Researchers created a test to measure growth hormone in channel catfish and used it to see how two substances—bovine GHRH and a synthetic peptide called GHRP‑2 (KP‑102)—affect hormone levels. They found that both the peptide and moving the fish from fresh water to salty water raised the fish's growth hormone dramatically.
Abstract
We report the development of a sensitive, and specific, competitive, antigen-capture enzyme-linked immunosorbent assay for the measurement of channel catfish (Ictalurus punctatus) growth hormone (cfGH). The detection limit of the assay (90% binding) was 2.0ng/ml and the ED(50) value (standard curve range 150-0.59 ng/ml) was 67.3 ng/ml. Recovery of cfGH-spiked plasma samples was determined to be 102%. Dose-response inhibition curves using serially diluted pituitary homogenates and plasma samples consistently showed parallelism with the standard curves using purified cfGH. The GH antibody (rabbit anti-catfish GH) specificity was demonstrated in competitive binding curves employing heterologous hormones and purified channel catfish prolactin (cfPRL). These studies show that there was no significant (0.006%) binding of cfPRL (competitive inhibition of cfGH binding), or heterologous hormones, within the working range of the assay. To physiologically validate the assay, catfish were injected (100 microg/g body weight, 3 injections every 5 days) with either bovine GHRH(1-29)-amide or the synthetic hexapeptide GHRP-2 (KP-102: D-Ala-D-beta-Nal-Ala-Trp-D-Phe-Lys-NH(2)) suspended in corn oil. Following the last injection, half of the animals were sampled for plasma and the remaining transferred from fresh water (FW) to 12 ppt seawater (BW: brackish water). Twenty-four hours after transfer to BW, animals were again sampled for plasma. Plasma GH levels were significantly (p<0.001) elevated in all the BW groups (control, KP-102, and bGHRH), compared with the FW (fresh water) groups. In addition, plasma GH levels were significantly (p<0.001) elevated by treatment with either of the GH secretogogues, KP-102 or bGHRH. Our findings demonstrate that two regulatory mechanisms of GH elevation, one which is seen in euryhaline teleosts (salinity-induced GH levels) and another, which has been recently described in teleosts (GHRP-induced GH levels), are present in the stenohaline channel catfish.
Study Information
pubmed
2003
2003-10-01T00:00:00.000Z
10.1016/s0016-6480(03)00194-1